Ozempic Copies Restricted After US Judge Denies Injunction
A US judge has denied a bid by compounding pharmacies to continue making copies of Novo Nordisk’s diabetes and weight-loss drugs Ozempic and Wegovy. The decision comes after a February lawsuit from the Outsourcing Facilities Association, which claimed there was still a shortage of the medicines’ active ingredient semaglutide. Compounders, also known as compounding pharmacies, … Read more